Knowledge Leaders Capital’s Alexion Pharmaceuticals ALXN Stock Holding History

Knowledge Leaders Capital’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,320	Closed	-$610K	–	137
2021 Q2	$610K	Buy	3,320 +40	+1%	+$6.87K	0.41%	103
2021 Q1	$502K	Hold	3,280	–	–	0.4%	95
2020 Q4	$512K	Hold	3,280	–	–	0.45%	82
2020 Q3	$375K	Hold	3,280	–	–	0.36%	98
2020 Q2	$368K	Buy	+3,280	New	+$348K	0.37%	96

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Knowledge Leaders Capital's ALXN Position: Q3 2021 in Review

Knowledge Leaders Capital sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 3,320 shares — an estimated $610K sold.

Knowledge Leaders Capital first reported a position in ALXN in Q2 2020 and held it in 5 quarters. The position peaked at $610K in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

Knowledge Leaders Capital reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Knowledge Leaders Capital sold 3,320 Alexion Pharmaceuticals shares in Q3 2021, an estimated $610K.
Knowledge Leaders Capital first reported a position in Alexion Pharmaceuticals in Q2 2020 and held it in 5 quarters.
Knowledge Leaders Capital's Alexion Pharmaceuticals position peaked at $610K in Q2 2021.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Knowledge Leaders Capital's 13F filing for Q3 2021, filed 4 Nov 2021.